ENTITY
Celltrion Healthcare

Celltrion Healthcare (091990 KS)

214
Analysis
Health Care • South Korea
Celltrion Healthcare Co.,Ltd develops and manufactures pharmaceutical biologics and chemically synthesized drugs. The Company specializes in the development of drugs for breast cancer, arthritis, leukemia, psoriasis, human rabies prevention, and influenza. Celltrion Healthcare markets its products to customers internationally.
more
bearish•Celltrion Healthcare
•28 May 2018 07:10

A Further Study on Celltrion-Celltrion Healthcare Market Cap Spread Movement

Last Friday (May 25) was a huge day for Celltrion Healthcare (091990 KS) which ended the day with a 7.17% gain. What was the main reason behind...

Logo
477 Views
Share
bearish•Samsung Biologics
•25 May 2018 10:35

FSC Chairman Speaks on Decision Framework

An article in the 24 May issue of BusinessKorea  (link below) reports on a talk given by Financial Services Commission (FSC) Chairman Choi...

Share
bearish•Samsung Biologics
•01 May 2018 22:55

Samsung Biologics' Accounting Violation's Impact on Samsung C&T and Rest of the Korean Pharmas

On May 1st, 2018, Korea's Financial Supervisory Service (FSS) announced that Samsung Biologics Co., Ltd (207940 KS) violated accounting rules after...

Logo
309 Views
Share
bearish•Celltrion Inc
•09 Apr 2018 05:43

Celltrion's FDA CRL Issue Summary

Celltrion Inc (068270 KS) is still right at the center of attention among Korean stock short sellers despite its KOSPI move.What is more critical...

Logo
403 Views
Share
bearish•Celltrion Inc
•11 Mar 2018 12:36

Celltrion Holdings' â‚©200bil CB with Celltrion Healthcare as Pledged Article - Questions to Ask

Mar 2 and Mar 5, Celltrion Holdings made two regulatory filings regarding its ₩200bil CBs issued to 'the Genesis #1 Limited Liability Company'...

Logo
549 Views
Share
x